Baird Medical Investment Holdings Ltd Ordinary Share (BDMD)
$0.1291▲ +18.33%
Close Nov 5, 2026 · split-adjusted
Nov 5, 2026$0.13▼ 89.33% in range
Nov 4, 2025Low $0.11 · High $3.44Nov 5, 2026
What changed · written from our data
As of Nov 5, 2026
Baird Medical Investment Holdings Ltd Ordinary Share closed at $0.13 on Nov 5, up 18.33%, 96.2% below its 52-week closing high. Volume of 302.8M shares was 28.39× its 20-day average (well above normal).
Split-adjusted performance: -83.7% over one month, -93.1% over six months, -89.3% over one year.
Short interest was 22.7K shares at the Oct 15 settlement, down 15.6% from the prior report (0.2% of float, 1.0 days to cover).
What does Baird Medical Investment Holdings Ltd Ordinary Share do?
Baird Medical Investment Holdings Ltd is a specialized healthcare innovator dedicated exclusively to thyroid-related diseases and a microwave ablation (MWA) medical device manufacturer and provider in China. The company combines clinical expertise with technologies to develop non-invasive treatment solutions.
What is BDMD's market cap?
$4.15M, based on the Nov 5 close of $0.13.
How much of BDMD is sold short?
22.7K shares, 0.2% of float, as of Oct 15, 2026.
About Baird Medical Investment Holdings Ltd Ordinary Share
Baird Medical Investment Holdings Ltd is a specialized healthcare innovator dedicated exclusively to thyroid-related diseases and a microwave ablation (MWA) medical device manufacturer and provider in China. The company combines clinical expertise with technologies to develop non-invasive treatment solutions. Its proprietary MWA medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Its core activities include the development and commercialization of thyroid microwave ablation systems and an active R&D pipeline of AI-integrated robotic systems, integrating hardware, software, and system-based solutions.
146 employeesListed Oct 2, 2024
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology